Many polycation-based gene delivery vectors show high transfection in vitro, but their 25 cationic nature generally leads to significant toxicity and poor in vivo performance which 26 significantly hampers their clinical applicability. Unlike conventional polycation-based 27 systems, decationized polyplexes are based on hydrophilic and neutral polymers. They are 28 obtained by a 3-step process: charge-driven condensation followed by disulfide crosslinking 29 stabilization and finally polyplex decationization. They consist of a disulfide-crosslinked 30 poly(hydroxypropyl methacrylamide) (pHPMA) core stably entrapping plasmid DNA (pDNA), 31 surrounded by a shell of poly(ethylene glycol) (PEG). In the present paper the applicability 32 of decationized polyplexes for systemic administration was evaluated. Cy5-labeled 33 decationized polyplexes were evaluated for stability in plasma by fluorescence single 34 particle tracking (fSPT), which technique showed stable size distribution for 48 h unlike its 35 cationic counterpart. Upon incubation of the polymers used for the formation of polyplexes 36 with HUVEC cells, MTT assay showed excellent cytocompatibility of the neutral polymers. 
show great instability in vivo, since they interact with negatively charged blood components 23 (e.g. proteins, erythrocytes), followed by the formation of aggregates, leading to severe in 24 vivo toxicity (lung embolism and/or liver necrosis) and uncontrollable biodistribution and off-25 targeting transfection [10] [11] [12] . Furthermore, cationic polymers/dendrimers might induce 26 immunogenicity, complement activation and even blood coagulation [12] [13] [14] . 27 Several strategies have been proposed and investigated to improve the in vivo behavior 28 of polyplexes. Coating of polycation-based systems with PEG, effectively avoids formation 29 of aggregates and reduces protein binding, resulting in improvements of the circulation 30 kinetics and tumor accumulation in vivo [12, 15, 16] . Another strategy to improve polyplex 31 stability consists of the incorporation of disulfide crosslinks into the polyplex core. Disulfide 32 crosslinks stabilize the polyplex structure in the bloodstream, avoiding unwanted 33 disassembly in circulation, but these bonds can be rapidly cleaved in the intracellularbasis. Introduction of biodegradability into cationic polymers lead to the development of safer 12 systems [5, 24] . However, during the development of new gene delivery polymer, toxicity is 13 measured with cell viability assays in limited concentrations and exposure times, likely 14 leading to underestimation of the toxicity problem. Toxicity is a complex process and 15 requires deeper analysis at both acute and long term basis. When cationic polyplexes are 16 taken up by cells, they will firstly compromise the cell membrane integrity [25] [26] [27] . 17
Polycations can also disrupt the cell homeostasis by interaction with cellular polyanions (e.g. 18 cell receptors, enzymes, mRNA or genomic DNA) [28] . Polycations can change the genomic 19 expression profile [29] [30] [31] and induce activation of oncogenes or even apoptosis [26, 32] . 20 Such consequences are directly related to the polycationic nature of synthetic vectors and 21 have a substantial impact on the safety of such systems. Accordingly, neutral polymer based 22 systems are a logical step to obtain not only improved blood circulation kinetics and 23 biodistribution but also to accomplish the necessary safety requirements. 24
In previous work the development of decationized polyplexes was reported [33, 34] . 25
These polyplexes constitute of a core of disulfide-crosslinked pHPMA, surrounded by a PEG 26 shell. Complexation with DNA to form polyplexes occurs by the transient presence of cationic 27 charge in the core of the polyplexes. After structure stabilization by interchain disulfide 28 crosslinking, the cationic groups are removed by hydrolysis, leading to a disulfide 29 crosslinked polyplex based on a neutral polymer. As a result, entrapment of pDNA is 30 exclusively based on disulfide crosslinks, providing an intracellularly triggered release 31 mechanism. This means that pDNA release from decationized polyplexes occurs exclusively 32 in a reducing environment, such as the intracellular milieu [17] [18] [19] . Importantly, the 33 decationized polyplexes, in contrast to their cationic precursor, showed a low degree ofTo determine the coupling efficiency, the crude product was diluted to a final polymer 23 concentration of 1 mg/mL in DMF containing 10 mM LiCl and analyzed by GPC equipped 24 with a UV detector set at 646 nm for Cy5 and 700 nm for Cy7 detection. The coupling 25 efficiency was determined by analyzing the area under the curve (AUC) of the polymer and 26 unreacted dye peaks. AUC was determined using GraphPad Prism 5 (GraphPad Software 27 Inc., La Jolla, California, USA). 28 A 1 M DMAE-CI solution in DMSO (451.5 µmol), corresponding to a 10-fold excess to 29 HPMA reactive groups of the polymer, was added to the reaction mixture. The reaction was 30 performed at room temperature for 24h, in the dark and N2 atmosphere to yield p(HPMA-31 DMAE-co-PDTEMA-co-Cy5/Cy7)-b-PEG (Scheme 2). After completion of the reaction, 1 M 32 acetic acid was added to adjust the pH 5. Removal of free dye was performed by dialysismethod previously described (Scheme 3) [33] . In order to prepare a high concentrated 23 polyplex dispersion 400 μg/mL pDNA, 80 µL of aqueous solution of pHDP-PEG was mixed 24 with 160 µL pDNA (pCMV_EGFP) (600 μg/mL) in 10 mM HEPES 10 mM TAPS pH 8.5 buffer 25 containing 5% glucose. The amount of polymer added to the pDNA solution corresponded 26 to N/P=4 (N, molarity of positively charged amines from polymer; P, molarity of negatively 27 charged phosphates from pDNA)). Subsequently, the formed polyplexes were crosslinked 28 by addition of dithiothreitol (DTT) corresponding with a half molar equivalent to PDS groups 29 of the polymer, in order to induce self-crosslinking of the polyplexes [45] for 1 h at pH 8.5 at 30 room temperature. 31
To prepare decationized pHP-PEG polyplexes, the cationic DMAE side groups were 32 removed by hydrolysis by incubation of the polyplex dispersions at 37 °C in 10 mM HEPES 33 cationic pHDP-PEG polyplexes the pH was adjusted to pH 7.4 immediately after completion 1 of the crosslinking step. When polyplexes needed to be stored for long periods, the pH of 2 the dispersions was adjusted to pH 5 and the dispersions were stored at 0-5 ºC, with the pH 3 being readjusted to pH 7.4 immediately before use. Comparative studies were always 4 performed by dividing the same batch of polyplexes into pHDP-PEG cationic and pHP-PEG 5 decationized polyplexes. Given the fact that the side products from cross-linking and 6 decationization (2-mercaptopyridine and DMAE) have a high cellular tolerance [33, 45, 46] , 7 the polyplexes were directly used without purification procedures. The size of the polyplexes was measured with DLS on an ALV CGS-3 system (Malvern 12
Instruments, Malvern, UK) equipped with a JDS Uniphase 22 mW He-Ne laser operating at 13 632.8 nm, an optical fiber-based detector, a digital LV/LSE-5003 correlator with temperature 14 controller set at 25 °C or 37 °C. Measurements were performed in HBS (20 mM HEPES, 15 150 mM NaCl, pH 7.4) at a pDNA concentration of 40 µg/mL. 16 Size distribution and polydispersity of the polyplexes were also determined by 17 nanoparticle tracking analysis (NTA) measurements on a NanoSight LM10SH (NanoSight, 18
Amesbury, United Kingdom), equipped with a sample chamber with a 532-nm laser. 19
Polyplexes were diluted in phosphate buffered saline (PBS) to a concentration of 0.1 µg/mL 20 pDNA and measured for 160 s with manual shutter and gain adjustments. The captured 21 videos were analyzed by the NTA 2.0 image analysis software (NanoSight, Amesbury, UK). 22
The detection threshold was set to 2 and the minimum track length to 10. The mode and 23 mean size and SD values were obtained by the NTA software. 24
The zeta potential (ζ) of the polyplexes was measured using a Malvern Zetasizer Nano-25 Z (Malvern Instruments, Malvern, UK) with universal ZEN 1002 'dip' cells and DTS (Nano) 26 software (version 4.20) at 25 °C. Zeta potential measurements were performed in 20 mM 27 HEPES pH 7.4 at a pDNA concentration of 10 µg/mL. 28 29 2.9. Stability using fluorescence single particle tracking (fSPT) 30 fSPT was performed to measure the stability of the cationic pHDP-PEG polyplexes and 31 decationized pHP-PEG polyplexes in full human plasma. fSPT is a fluorescence microscopy 32 technique that uses wide-field and a fast and sensitive CCD camera to record movies ofdiffusing particles in biofluids. These movies are analyzed using in-house developed 1 software, to obtain size distributions as previously described [36] . 2 fSPT measurements were performed as follows: a volume of 5 µL of sample of Cy5-3 labeled polyplex dispersion in HEPES buffer (20 mM pH 7.4) or in fresh plasma (10 µg/mL 4 final pDNA concentration) was placed between a microscope slide and cover glass with 5 double-sided adhesive sticker, following incubation for different time points at 37 °C. Both 6 the objective and the sample were kept at 37 °C during the measurements using an objective 7 heater (Bioptechs, Butler, USA) and a sample heater (Linkam, Surrey, U.K.). Videos were 8 recorded with the NIS Elements software (Nikon) driving the EMCCD camera (Cascade 9 II:512, Roper Scientific, AZ, USA) and a TE2000 inverted microscope equipped with a 100_ 10 NA1.4 oil immersion lens (Nikon). To convert SPT diffusion measurements to size 11 distributions, the viscosity of human plasma at 37 °C was set to 1.35 cP [36] . Human plasma 12 was obtained from a healthy donor at UMC Utrecht. Blood was collected in EDTA tubes 13 which were cooled on ice and subsequently centrifuged at 4 ºC, 2000 ×g for 10 min and 14 plasma was isolated and stored at -80 ºC. 15 
MTT assay 26
The cell viability upon incubation with decationized pHP-PEG and cationic pHDP-PEG 27 polymers was evaluated via MTT assay, which measures the cellular metabolic activity of 28 the cells. HUVECs were seeded into 96-well plates: 12,000 cells were seeded per well for 29 24 h test and 1,950 cells per well were seeded for the 72 h test. After 24 h, the medium was 30 refreshed and 30 µL of polymer samples in PBS was added to each well corresponding to 31 a final concentration of 0.01-3 mg/mL also containing 12% FBS. After 24 h or 72 h, the MTT 32 assay (Roche) was performed according to the manufacturer's protocol. First, cells werelabeling reagent was added to a final concentration of 0.5 mg/mL. After 4 h at 37 ºC and 5% 1 CO 2 , the medium was discarded and 100 μL of DMSO was added per well to dissolve the 2 formed formazan crystals. The plate was protected from light and formazan crystals were 3 dissolved overnight at room temperature. The supernatants (100 µL) were then transferred 4 into another 96-well plate and the absorbance was measured at 570 nm using reference 5 wavelength of 690 nm. 6 7 2.12. In vivo toxicity using the zebrafish embryo assay 8
The in vivo toxicity of decationized pHP-PEG and cationic pHDP-PEG polymers was 9 evaluated using the zebrafish (Danio rerio) embryo assay based on the method previously 10 described in detail by Rizzo et al. [37] . In short, fertilized eggs were transferred into round-11 bottom 96-well plates (16-cell stadium, 1 egg per well). Polymers were diluted in fish medium 12 corresponding to polymer concentrations ranging from 0.1 to 3 mg/mL. As positive control, 13 branched polyethylenimine (b-PEI) 25 kDa was tested at 0.1 mg/mL. The development and 14 survival of the zebrafish embryos was evaluated for 72 h every 24 h post-fertilization using 15 a Leica DMI 6000B inverted microscope. Imaging, Erlangen, Germany) and 3D FMT imaging (FMT2500; PerkinElmer), were 28 performed essentially as previously described [38] . Briefly, mice were placed in a multi-29 modal imaging cassette under anesthesia (2% of isoflurane) to be firstly scanned in a µCT. 30
Images with an isotropic voxel size of 35 µm were reconstructed using a modified Feldkamp 31 algorithm with a smooth kernel. Immediately after µCT procedure, the animals were placed 32 into the FMT docking station under 2% isoflurane anesthesia. The excitation wavelength 33 channel was set to 750 nm. Whole body images of the mice were captured using FRI toallow the definition of the region of interest (ROI) and 3D scans were performed. µCT and 1 3D FMT images were collected 15 min, 4 h, 24 h and 48 h post-injection. 2
The obtained μCT and FMT scans were fused. Based on the μCT data, liver, kidneys, 3 lungs, heart, bladder and tumor were segmented, using an Imalytics Research Workstation 4 software (Philips Technologie GmbH Innovative Technologies, Aachen, Germany). FMT 5 reconstructed signals were overlapped onto respective organ-segmented μCT images, and 6 the amount accumulated Cy7 in these organs was quantified. The percentage injected dose 7 (% ID) was calculated based on the quantification obtained for each segmented organ and 8 normalized to the organ volume. In parallel to the imaging protocol, blood and urine samples 9
were also collected at relevant time 2 min, 15 min, 1 h and 4 h for blood and 1 h, 4 h and 24 10 h for urine collection. 11 12
Ex vivo analysis 13
Mice were injected intravenously with rhodamine-labeled lectin (Vector Laboratories, 14 LTD, UK), for staining of blood vessels, 15 min before sacrifice and 48h after sample 15 injection. Tumors, liver, spleen, heart, lungs, uterus, intestines, muscle and skin were 16 The stability evaluation by fSPT and the in vivo evaluation by 3D-FMT of decationized 10 polyplexes required the synthesis of Cy5-and Cy7-labeled pHDP-PEG. which was 11 performed in 3 steps (Scheme 1). First, p(HPMA-co-PDTEMA-co-APMA)-b-PEG was 12 synthesized via free-radical polymerization of HPMA, PDTEMA and APMA using mPEG) 2 -13 ABCPA as a PEG5000 bi-functionalized azo macronitiator [40] (Scheme 1). The yield of 14 polymerization was close to 75%. The results of the analysis of the polymer by 1 H NMR (Fig.  15 1), GPC and TNBSA assay are given in Table 1 NHS-functionalized dyes were conjugated to p(HPMA-co-PDTEMA-co-APMA)-b-PEG by 5 reaction with the primary amines of APMA for 36 h using a 2 molar excess of reactive dyes 6 (Scheme 2). After reaction, the crude product was analyzed with GPC, and the coupling 7 efficiency was determined by GPC analysis of the AUC of the polymer and unreacted dye 8 peaks (detection at 646 nm (Cy5 coupling) or 700 nm (Cy7 coupling)). The obtained 9 chromatograms revealed that the AUC for each peak was close to 50% for both reactions, 10 demonstrating that the amine groups of the polymers were quantitatively modified with dye 11 molecules. In Fig. 2a shows the GPC chromatogram of the crude product from Cy7 coupling 12 reaction. In the third step, the crude product (e.g. p(HPMA-co-PDTEMA-co-(Cy5/Cy7)-b-13 PEG) was reacted with DMAE-CI (Scheme 2) to yield the cationic polymer p(HPMA-DMAE-14 co-PDTEMA-co-(Cy5/Cy7)-b-PEG. After purification of the polymer by extensive dialysis, 1 H 15 NMR ( Fig. 1) showed that the integral ratio between peaks at δ4.2 ppm (bs, OCH 2 CH 2 ), 16 HPMA-DMAE) and δ4.6 ppm (bs, CH 2 CHCH 3 O, HPMA-DMAE) was close to 2, confirming 17 a quantitative reaction of the OH groups of HPMA with DMAE-CI. GPC analysis of the final 18 purified products showed complete removal of the unreacted dyes for both Cy5-and Cy7-19 labeled polymer (e.g. Fig. 2b for Cy7-labeled polymer). The modification of HPMA groups 20 with the cationic DMAE groups after dye coupling was chosen over the direct polymerization 21 of HPMA-DMAE monomer [33, 34] 
Preparation of fluorescently labeled decationized pHP-PEG polyplexes 8
Polyplexes of pHP-PEG were formed through the 3-step process [33, 34] An overview of the biophysical properties of both the decationized pHP-PEG and cationic 7 pHDP-PEG polyplexes by DLS and zeta potential measurements is shown in Table 2 . 8
Polyplexes were prepared by complexing the polymer with pDNA at an optimal N/P=4 9 regarding their biophysical and in vitro transfection properties [33] . Firstly, pHDP-PEG 10 formed nanosized particles with a diameter of 140±5 nm and a positive zeta potential of 11 +11±3. After decationization, pHP-PEG polyplexes had a size of 142±8 nm and a slightly 12 negative zeta potential of -4±2 mV. The decrease in zeta potential, from cationic to 13 decationized arises from to the loss of the cationic DMAE groups from the pHDP and from 14 the entrapped pDNA in the core [33] . The loss of electrostatic interactions between the 15 polymer and pDNA potentially leads to some hydration and thus slight swelling of the 16 polyplex core, however by using a zero-length crosslinking agent such as DTT, this effect is 17 limited. Size is a particularly critical property for the biodistribution of nanoparticles [47] , 18 however, here this variable is ruled out by evaluation polyplexes of very similar size. 19
Both decationized pHP-PEG and cationic pHDP-PEG polyplexes were complementarily 20 analyzed by NTA, a technique that allows the simultaneous analysis of individual particles 21 in a suspension and gives information of the true size distribution (Fig. 3) 
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Stability of decationized pHP-PEG polyplexes in human plasma 15
The stability of cationic pHDP-PEG and decationized pHP-PEG Cy5-labeled was 16 evaluated by incubation at 37 ºC in human plasma. The size distribution of the polyplexes 17 in plasma was determined by fSPT and compared to the distributions obtained when 18 polyplexes were diluted in HEPES buffer pH 7.4 (Fig. 4) . The method is based on single 19 particle tracking analysis of fluorescent particles which allows the determination of precise 20 size distributions in media with intrinsic light scattering such as undiluted biological fluids 21 [36] . The fSPT technique is especially important to gain information on the possible 22 aggregation of nanoparticles. When Cy5-labeled polyplexes, both cationic and decationized, 23
were measured in HEPES buffer by fSPT, comparable size distributions to the ones 24 obtained by DLS and NTA were observed. The distribution was relatively narrow, with a 25 peak around 200 nm. When the cationic pHDP-PEG polyplexes were incubated in human 26 plasma for 1 h, a clear change in the distribution profile was observed and a higher average 27 size (~300 nm) as well as polyplexes with >400 nm in diameter were clearly detected. Upon 28 incubation for 48 h, the average size (560 nm) and the population of polyplexes withdiameter >400 nm was increased. The instability detected for crosslinked cationic 1 polyplexes likely occurs is due to insufficient shielding of the positive charge of the 2 polyplexes by PEG and consequent interaction of polyplexes with negatively charged 3 proteins from plasma. Indeed, table 2 shows that the cationic pHDP-PEG polyplexes have 4 a positive zeta-potential. Importantly, when pHP-PEG decationized polyplexes were 5 incubated with human plasma for 1 h, only a slight change of the size distribution was 6 observed, and the peak of the distribution remained unchanged. Consequently, crosslinked 7 decationized polyplexes retained their integrity in biological fluids, and did not show 8 aggregation (mediated e.g. by plasma proteins). For example, almost no polyplexes with a 9 diameter of >400 nm were detected which is in great contrast with the cationic polyplexes. 10
In line with this, also after incubation the polyplexes for 48 h the size distribution only 11 changed slightly, without any aggregation detected. A slight increase in size after 48 h 12 probably occurs due to protein adsorption to the polyplexes as a consequence of loss of 13 PEG density due to continuous hydrolysis of the ester bond linking PEG chains with HPMA-14 co-PDTEMA block. PEG is essential to stabilize nanoparticles, avoid aggregation and 15 protein adsorption in blood. This is quite evident for cationic particles [12, 15, 16], but 16 essential for anionic particles as well [49, 50] . 17
The stability assessment is especially important for systemic administration of polyplexes. 18 
In vitro and in vivo toxicity assessment 6
To assess the toxicity of the decationized pHP-PEG and cationic pHDP-PEG, the 7 polymers were evaluated in vitro with HUVEC cells via MTT assay in an acute (24 h) and a 8 long term toxicity test (Fig. 5a ) and in vivo with a zebrafish embryo model (Figs. 5b and 5c) 9 with different polymer concentrations (0.1 to 3 mg/mL). The cationic polymer b-PEI, a 10 commonly used transfection agent, was used as a positive control for toxicity [37] . 11
The in vitro toxicity was tested in HUVEC cells due their high sensitivity towards 12 transfection agents [54] . The MTT test revealed that decationized pHP-PEG had no effect 13 on the cell viability, in any of the concentrations tested, when incubated with the cells for 24 14 h. Only a slight decrease on the cell viability was found in case incubation was prolonged 15 for 72 h. The in vitro evaluation of the cationic pHDP-PEG polymer showed that the polymer 16 lead to decrease in cell viability with increasing concentrations, to a level of 70% cell viabilitycytotoxic effects were even more pronounced and at 1 mg/mL already lead to decrease in 1 cell viability to 20%. In the case of b-PEI extreme toxicity was observed, at the lowest 2 concentration tested (0.1 mg/mL) b-PEI induced complete cell death in both acute and long 3 term in vitro toxicity test. 4
The zebrafish eggs were incubated with increasing polymer concentrations, and 5 teratogenic effect and the mortality potential on the different zebrafish embryonic stages 6
were monitored microscopically for a period of 72 h. The neutral polymer pHP-PEG showed 7 no effect on the fish viability for any of the concentrations tested. Developmental defects 8 and delayed hatching were observed only for the highest concentration tested (3 mg/mL). 9
For the cationic polymer pHDP-PEG a significant decrease on zebrafish viability was 10 observed at 3 mg/mL, resulting in 100% fish death at 72 h. Mortality was also detected at a 11 very early stage of the development (1 out of 6) together with a slower heartbeat in the 12 surviving ones. Furthermore, the cationic pHDP-PEG also interfered significantly in the 13 embryonic development of the fishes. A decrease in the pigmentation was observed from a 14 concentration of 0.3 mg/mL onwards, no hatching was observed at 48 h for 1 mg/mL and at 15 3 mg/mL all fish had a decreased heartbeat. In line with the in vitro test, b-PEI was again 16 responsible for extreme toxicity, by inducing complete fish death at 0.1 mg/mL even at early 17 stages of development. 18 In parallel with 3D µCT-FMT images, blood circulation kinetics was determined by 2D FRI 1 signals of blood and urine collected at different time points p.i (Fig. 6) . Quantification of 2 polyplex signals in blood showed that there was a very rapid decrease of the %ID for both 3 cationic and decationized polyplexes which typical for polyplex systems when administered 4 intravenously [15, 16, 22, 57, 58] (Fig. 6a) . Importantly, a significant higher blood circulation 5 time was observed for decationized pHP-PEG polyplexes. Decationized polyplexes showed 6 a higher signal in blood at all time points when compared to cationic pHDP-PEG. The 7 elimination rate via kidneys was determined by detecting 2D FRI signals from urine (Fig.  8   6b) . High Cy7 %ID was detected in urine 15 min p.i. for both groups, followed by a rapid 9 decrease 4 h p.i. Most likely, this was due to a rapid glomerular filtration of low Mw polymer 10 fraction that is not built in the polyplexes. This fraction of polymers is the same for both 11 cationic and decationized polyplexes, as confirmed by the similar signals found for both 12 polyplexes. 
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As shown in Fig. 7 , using µCT imaging, tumors, liver, heart, lungs, kidneys and bladder 20 were manually segmented, to assign the NIR fluorescence signals from the polyplexes at 21 different times points, as previously described lower transfection ability of decationized polyplexes is therefore likely attributed to its low 2 degree of unspecific uptake. We also showed that uptake can be triggered by introduction 3 of a targeting ligand at the surface of decationized polyplexes [33, 34] . Furthermore, 4 introduction of targeting ligands is important to accelerate the rate of cellular uptake of 5 polyplexes and prevent premature reduction of disulfide crosslinks before cell entry due to 6 the presence of secreted and cell membrane thiols [67] . Cationic polyplexes, in contrast, are 7 known to be taken up extensively by electrostatic interaction with cell membrane anionic 8 components [3, 68, 69] . The transfection ability of cationic pHDP-PEG polyplexes is in line 9
with previous findings of pHPMA-DMAE to induce in vivo transfection in tumors [70] . 10
It should be noticed that the ability of cationic polyplexes to transfect cells more efficiently 11 has counterproductive effects because it also leads to an increased probability of off-12 targeting expression, especially when high accumulation is observed in liver, spleen and 13 kidneys. Unwanted transfection in healthy organs has been previously observed particularly 14 in liver and lungs [16, 22, [34] . Furthermore, due to its low toxic and low teratogenic potential, 18 decationized polyplexes are less limited to dose and repeated administration restrictions, 19 resulting in a promising and attractive system for further optimization strategies and testing. 20
Future studies have to be focused on deeper evaluation of transfection ability of optimized 21 formulations of decationized polyplexes. Optimization for a better in vivo performance can 22 be done by using targeted systems or by optimizing the polymer structure, for example by 23 determining the best PEG block molecular weight and density [73, 74] or by introduction of 24 hydrophobic groups in the core of polyplexes groups into polyplexes [75] .In a next step, 25 therapeutic genes should be used to determine the therapeutic potential of decationized 26 polyplexes. and inducing EGFP expression (green). Blood vessels are labeled using rhodamine-lectin (red).
8
Results are expressed as mean±SD (n=3). *p<0.05 (t test). 9 10 11
CONCLUSIONS 12
Decationized polyplexes, unlike conventional polycationic polymeric gene delivery systems, 13 are based on neutral polymers. In the present study, we demonstrate that the neutral 14
polymer pHP-PEG when tested for toxicity in vitro with HUVEC cells showed a very good 15 cytocompatibility in both acute and long term toxicity test. Furthermore, an in vivo zebrafish 16 toxicity assay revealed that pHP-PEG did not induce fish mortality and, importantly, showedapparent safe polymer formed polyplexes with a high stability in biological fluids, as 1 determined by fSPT, which validated its applicability in vivo applicability for systemic 2 administration. Using noninvasive optical imaging (3D µCT-FMT) and complementary ex 3 vivo analysis we demonstrated that by removing the cationic groups of polyplexes, we 4 obtained a system with higher tumor accumulation, most likely due to their longer blood 5 circulation and apparent decreased accumulation in healthy organs. Ex vivo analysis 6 validated the optical imaging results and histology in tumor crysections and showed that 7 decationized polyplexes induced transgene expression in vivo. 8
The described strategy for preparing decationized polyplexes and the results reported are 9 an important contribution to take into consideration to develop safer and more efficient 10 nonviral gene delivery systems. 11 12
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